Navigation Links
Enso Discoveries, LLC Appoints Vice President, Trey Pittman, to Head National Veterinary Histopathology Laboratory and Animal Health Division
Date:4/14/2020

Enso Discoveries is proud to announce Trey Pittman, Vice President of Animal Health will now lead the national campaign for the newly launched histopathology laboratory in addition to the national division of veterinary regenerative medicine products. After a successful year of launching Enso Discoveries Rebound PRP and Rebound PRF devices into both national and international veterinary supply distributors, Pittman is uniquely positioned to pair Enso Discoveries Animal Health offerings with histopathology services for the benefit of patient care, practice growth, and long-term industry stability.

“As a rapidly growing biotech company one of our ongoing critical needs is to ensure we have exceptional talent to effectively manage our rapid growth. Pittman has exceeded my expectations since joining Enso Discoveries and is uniquely positioned to lead the Animal Health Division for the company. His intellect, passion, complete understanding of the veterinary market and amazing work ethic gives me the confidence to know he is the right man for the job. Everybody should be so lucky as we were, to hire a man like Pittman,” states Patrick Farley, CEO, Enso Discoveries.

“We do our best to understand and anticipate the needs of the current and future veterinary market, then we develop partnerships with experts in their fields to deliver efficient growth drivers and service-based revenue opportunities to our veterinary customers. Enso is already a part of this future, and we understand Love is at the core of our business — the love between a pet owner and pet-patient is the best reason we have to do our best work every day,” explains Trey Pittman, Vice President of Animal Health, Enso Discoveries.

Laboratory starter kits can be requested from EnsoDiscoveries.com. Any samples provided during the COVID-19 pandemic will be reduced by an additional 10% for the next three months, as a way to ease the economic stress and Enso Discoveries’ way of giving back to the veterinary and animal medical industry during these unusual circumstances. Enso Discoveries is a veteran-owned small business doing its part to keep essential services running through the pandemic.

Pittman brings over a decade of progressive veterinary sales and marketing experience to the company and plans to drive business growth, capitalize on new revenue potential, and manage all aspects of daily sales operations. He attributes his past successes in both the veterinary industry and human pharma in his ability to develop genuine trusting relationships that encourage collaboration between Company and Client, allowing for ever-improving products and services that help a company grow in both offering and revenue.

###

Enso Discoveries, LLC is a biotech company focused on enhancing the lives of animals through the development of relevant, cost-effective, novel technology that allows our valued customer, the veterinarian, to keep their hard-earned business in house. We support our products and services with scientific proof, national distribution partners, and a worldwide network of industry experienced contacts. Ask your veterinarian or veterinary products
distributor about Enso Discoveries, LLC products such as Rebound PRP™ and Rebound PRF® or learn more at http://www.ensodiscoveries.com.

Read the full story at https://www.prweb.com/releases/enso_discoveries_llc_appoints_vice_president_trey_pittman_to_head_national_veterinary_histopathology_laboratory_and_animal_health_division/prweb17047901.htm.


'/>"/>
Source: PRWeb
Copyright©2020 Vocus, Inc.
All rights reserved


Related biology news :

1. Covetrus North America Now Offers Unique In-Clinic Regenerative Medicine Devices by Enso Discoveries, LLC Including Rebound PRP™ and Rebound PRF®
2. American Chemical Society resource connects scientists, discoveries, chemistry & biology interface
3. ISPE Appoints Jean-François Duliere as a European Regulatory Advisor
4. Cytonus appoints Allergan executive Manisha Narasimhan, Ph.D. to its Board of Directors
5. Syntactx Appoints Dorothy Abel as Vice President, Regulatory Strategy
6. Advanced Clinical Appoints Dr. Pavel Tyan to Lead and Enhance Therapeutic Oncology Research
7. AbSci Appoints Biopharmaceutical Pioneer Dr. Fred Larimore to Executive Team
8. uBiome Appoints John Rakow as Interim Chief Executive Officer
9. uBiome Appoints Dr. Julia Oh, PhD, Skin Microbiome Researcher, to its Scientific Advisory Board
10. NDA Partners Appoints Deb Koeneman as Partner in the Firm
11. Visikol Appoints Pharmaceutical Industry Leader, Stewart Hunt, as Director of US Sales
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/5/2020)... Calif. (PRWEB) , ... June 04, 2020 , ... ... has filed a new patent application for simplified sample preparation for Next Generation ... that will greatly reduce cost, time, and complexity of sample preparation. , “I have ...
(Date:5/30/2020)... ... May 29, 2020 , ... eInfochips, ... enterprises globally, has collaborated with EchoNous Inc. to develop the cloud-based connected health ... systolic heart function, which has been clinically tested versus expert measurements, yielding improved ...
(Date:5/28/2020)... , ... May 28, 2020 , ... ... that interim results from their 1801 Phase 1/2 study (NCT03678883, EudraCT #: 2018-003739-32) ... Meeting which will take place virtually on May 29th, 2020. Dr. Benedito Carneiro, ...
Breaking Biology News(10 mins):
(Date:6/23/2020)... ... June 22, 2020 , ... Regen Suppliers, the ... This includes buy three, get the fourth unit free with no limit on ... exosomes, known as exosomes, have been a game changer for regenerative therapies. The ...
(Date:6/23/2020)... PORTLAND, Ore. (PRWEB) , ... June 23, 2020 ... ... advancement of innovative CNS therapies, today announced that it has filed an Investigational ... initiate a Phase 2b clinical trial of its lead drug candidate NBTX-001 in ...
(Date:6/11/2020)... , ... June 08, 2020 , ... ... vaccine platform delivered through the use of proprietary clean viral vectors, recently announced ... the United States. Greffex’s platform is the world’s most successful gene therapy ...
(Date:6/11/2020)... ... June 09, 2020 , ... TRX Systems, developer of ... Solution, a highly accurate, contact tracing solution for identification of employees who ... a core disease control measure, is a key strategy for preventing further spread ...
Breaking Biology Technology: